From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

The role of immune checkpoint inhibition in triple negative breast cancer

Last Updated: Monday, October 30, 2023

Data from the numerous trials that evaluated the role of immune checkpoint inhibition (ICI) monotherapy, dual therapy, ICI in combination with chemotherapy, targeted therapy, vaccines, and radiation in TNBC treatment are reviewed here, along with potential biomarkers of response and immune-related adverse events.

Expert Review of Anticancer Therapy
Advertisement
News & Literature Highlights
Advertisement
Advertisement